Reglan® & Tardive Dyskinesia Lawsuit

If you or a loved one have taken Reglan (Generic name: Metoclopramide) and been diagnosed with Tardive Dyskinesia, you should contact us immediately. You may be entitled to compensation and we can help.

UPDATE: On February 25, 2009, The U.S. Food & Drug Administration (FDA) required the manufacturers of metoclopramide-containing drugs (Reglan) to add a “Black Box” warning to the products warning of an increased risk of the development of Tardive Dyskinesia.  

The Effects of Tardive Dyskinesia

Tardive Dyskinesia (TD) is a devastating and sometimes lifelong syndrome for those diagnosed. It affects its victims physically, mentally, socially, emotionally, and vocationally.

One of the worst aspects of Tardive Dyskinesia for many victims is the fact that they should have never developed the syndrome in the first place.

Learn More:

• Tardive Dyskinesia Symptoms, Tests / Diagnosis and Treatment Information
• Detailed List of Symptoms Associated with Tardive Dyskineisa
• Schmidt & Clark, LLP Contacted by Reglan Users Claiming Irreversible Side Effects, Including Tardive Dyskinesia
• FDA Requires Boxed Warning and Risk Mitigation Strategy for Metoclopramide-Containing Drugs (pdf)

What You Can Do & How We Can Help – We are committed to helping victims of Tardive Dyskinesia. To our knowledge, we are one of the only law firms in the country actively handling these types of cases. Many lawyers are reluctant to undertake the representation of victims of this disorder due to their lack of knowledge in this highly specialized field of litigation.

What is the Problem?

The manufacturers of Reglan and its generic metoclopramide mention the link between the development of Tardive Dyskinesia and the drug on its labeling, however they suggest the incidence rarely occurs.

It is important to understand that the Food & Drug Administration has only approved Reglan for short-term use (4 to 12 weeks) and only when conservative treatment fails.

Safety experts from the Duke University School of Medicine, publishing in the November/December 2004 Journal of the American Pharmacists Association, caution that the use of Reglan is increasing and that this fact may result in more cases of drug-induced movement disorders from the medication.

Long-term use can cause serious Reglan side effects, including Tardive Dyskinesia.

FDA Warning on Reglan

Below, is a video published by the U.S. Food & Drug Adminsitration (FDA), which discusses the “Black Box” warning and the increased risk of the development of Tardive Dyskinesia among users of Reglan.

Do I have a Reglan Lawsuit?

The Defective Drug and Product Liability litigation Groups at our law firm are an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Tardive Dyskinesia lawsuits. We are handling individual lawsuits nationwide and currently accepting new Reglan induced Tardive Dyskinesia cases in all 50 states.

If you or a loved one have taken Reglan (Generic name: Metoclopramide) and been diagnosed with Tardive Dyskinesia, you should contact us immediately. You may be entitled to compensation and we can help.